Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment avenues
Our findings enhance the understanding of the dysfunction underlying CDS and propose new avenues for the treatment of CDS patients.
Authors
- Orly Dorot (ORCID: https://orcid.org/0000-0002-5467-2617)
- Emily Avitan‐Hersh (ORCID: https://orcid.org/0000-0002-2154-7609)
- Einat Zalckvar (ORCID: https://orcid.org/0000-0003-3724-3965)
- Galit Tal (ORCID: https://orcid.org/0000-0002-1166-3956)
- Ann Saada (ORCID: https://orcid.org/0000-0003-2951-0656)
- Yuval Kleinberg
- Karin Weiss (ORCID: https://orcid.org/0000-0003-0998-810X)
- Keren Oved
- Vanina Zaremberg
- Rinat Zaid
- Edward Pichinuk (ORCID: https://orcid.org/0000-0001-8488-8710)
- Victoria Li
- Tanmoy Newaz
- Mor Angel
Institutions
- Bar-Ilan University (IL)
- Tel Aviv University (IL)
- University of Calgary (CA)
- Technion – Israel Institute of Technology (IL)
- Jerusalem College of Technology (IL)
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- Jerusalem University College (IL)
- Rambam Health Care Campus (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Weizmann Institute of Science (IL)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1186/s13023-025-03711-6
- Citations
- 2
- Primary Topic
- Lipid metabolism and biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 2.22
Funders
- Natural Sciences and Engineering Research Council of Canada